I am attending the Executive War College on Lab and Pathology Management in New Orleans next week and I couldn’t be more excited. First, I am eager to see and learn from great lab minds from around the country. Second, I will be moderating a panel of incredible thought leaders from Alverno Laboratories, Avera Health System and Mayo Clinic Health System who will discuss how they have taken on the process of developing a next-level logistics infrastructure to enable the lab of the future.
Over the past couple of years, I have often written about the challenges confronting hospitals and health systems as a result of the Affordable Care Act. And now, new legislative changes in healthcare laws are impacting another segment of the healthcare supply chain: laboratories.
Two weeks ago in New Orleans, the 19th Annual Executive War College on Laboratory and Pathology Management brought together 800 clinical laboratory professionals and pathologists. One of the major topics covered was the legislation passed by Congress and recently signed into law by President Obama called “Protecting Access to Medicare Act of 2014” (PAMA). In his keynote address, Robert L. Michel, founder of the Executive War College, said that PAMA is the single biggest change to the clinical laboratory industry in more than 25 years.